Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean C Bendall

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Nature Immunology|January 21, 2022
The immunoregulatory landscape of human tuberculosis granulomasErin F McCaffrey, Michele Donato, Leeat Keren, et al.
Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.
Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.
Nature Immunology|February 23, 2026
The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomasErin F McCaffrey, Alea C Delmastro, Isobel Fitzhugh, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Nature Cancer|February 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBCNoah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Cancer Cell|December 12, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, et al.
Cancer Cell|July 19, 2016
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2Satoshi Inoue, Wanda Y Li, Alan Tseng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Nature Immunology|January 21, 2022
The immunoregulatory landscape of human tuberculosis granulomasErin F McCaffrey, Michele Donato, Leeat Keren, et al.
Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.
Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.
Nature Immunology|February 23, 2026
The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomasErin F McCaffrey, Alea C Delmastro, Isobel Fitzhugh, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Nature Cancer|February 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBCNoah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Cancer Cell|December 12, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, et al.
Cancer Cell|July 19, 2016
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2Satoshi Inoue, Wanda Y Li, Alan Tseng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Pageof 14